You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 12, December 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (25)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Transplantation, Other
 •Alert me on articles by topic

The Role of Thyroid Hormone Administration in Potential Organ Donors

Ali Salim, MD; Pantelis Vassiliu, MD; George C. Velmahos, MD; Jack Sava, MD; James A. Murray, MD; Howard Belzberg, MD; Juan A. Asensio, MD; Demetrios Demetriades, MD

Arch Surg. 2001;136:1377-1380.

Hypothesis  Levothyroxine sodium therapy should be used in brain-dead potential organ donors to reverse hemodynamic instability and to prevent cardiovascular collapse, leading to more available organs for transplantation.

Design  Prospective, before and after clinical study.

Setting  A surgical intensive care unit of an academic county hospital.

Patients  During a 12-month period (September 1, 1999, through August 31, 2000), we evaluated 19 hemodynamically unstable patients with traumatic and nontraumatic intracranial lesions, who were candidates for organ donation following brain death declaration.

Interventions  All patients were resuscitated aggressively for organ preservation by fluids, inotropic agents, and vasopressors. If, despite all measures, the patients remained hemodynamically unstable, a bolus of 1 ampule of 50% dextrose, 2 g of methylprednisolone sodium succinate, 20 U of insulin, and 20 µg of levothyroxine sodium was administered, followed by a continuous levothyroxine sodium infusion at 10 µg/h.

Results  There was a significant reduction in the total vasopressor requirement after levothyroxine therapy (mean ± SD, 11.1 ± 0.9 µg/kg per minute vs 6.4 ± 1.4 µg/kg per minute, P = .02). Ten patients (53%) had complete discontinuation of vasopressors. There were no failures to reach organ donation due to cardiopulmonary arrest.

Conclusions  Levothyroxine therapy plays an important role in the management of hemodynamically unstable potential organ donors by decreasing vasopressor requirements and preventing cardiovascular collapse. This may result in an increase in the quantity and quality of organs available for transplantation.


From the Department of Surgery, University of Southern California Keck School of Medicine and the Los Angeles County–University of Southern California Medical Center.


RELATED ARTICLE

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2001;136(12):1443-1444.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pediatric Organ Transplantation Needs: Organ Donation Best Practices
Bratton et al.
Arch Pediatr Adolesc Med 2006;160:468-472.
FULL TEXT  

Cardiac organ donor management
Ullah et al.
Perfusion 2006;21:93-98.
ABSTRACT  

Preservation of Organs from Brain Dead Patients
Bratton
AAP Grand Rounds 2005;13:21-22.
FULL TEXT  

Care of the Potential Organ Donor
Wood et al.
NEJM 2004;351:2730-2739.
FULL TEXT  

Strategies to increase limited donor resources
de Perrot et al.
Eur Respir J 2004;23:477-482.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.